Journal of Hepatology 2024

26 papers
The 2024 edition of the Journal of Hepatology highlights research centered on metabolic dysfunction-associated steatotic liver disease (MASLD) and the integration of computational tools in clinical diagnostics. A significant portion of the work focuses on refining screening methods for liver fibrosis, including the use of sequential algorithms like the ELF test and FIB-4 in populations with Type 2 Diabetes Mellitus. Notable studies also explore the development of home-based scores to detect advanced fibrosis and predict long-term liver outcomes. Technological trends include the application of artificial intelligence and deep learning to analyze whole slide images for collagen composition and to differentiate between autoimmune hepatitis and primary biliary cholangitis. Molecular investigations address potential therapeutic targets such as Claudin-1 for biliary fibrosis and the use of RNA editing for Alpha-1 antitrypsin deficiency. Additionally, research examines cellular processes like hepatocyte polyploidisation and its role in buffering the effects of aging. Prolific contributors to this year's volume include Jakob Nikolas Kather, Rajiv Jalan, and George Boon-Bee Goh.

Top Authors

AuthorPapers
Jakob Nikolas Kather3
Catia Perciani2
Sai W Chung2
Daniel Habermann1
Dennis L. Shung1
Dongmei Zhang1
Fabian J Theis1
Gary D. Bader1
Qinghe Zeng1
Qinghua Lu1
Roman Goldenberg1
Yi Jin1

Papers

Title
FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity
“Fatty” or “steatotic”: Position statement from a linguistic perspective by the Chinese-speaking community
FRI-151 RNA editing for the treatment of Alpha-1 antitrypsin deficiency
FRI-339 Obeticholic acid promotes the hepatic ductular reaction via macrophage-mediated Relb-TNFSF14 signaling in cholestasis
FRI-499-YI Counterfactual explanations for histopathology slides of hepatocellular carcinoma and cholangiocarcinoma enhance the understanding of artificial intelligence models
FRI-525 Phosphoinositide 3-kinase delta promotes plasticity and development of the microenvironment in cholangiocarcinoma
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replication
OS-017 Deep learning discriminates autoimmune hepatitis and primary biliary cholangitis
OS-040-YI Claudin-1 is a mediator and therapeutic target of biliary fibrosis by modulating liver progenitor cell fate and signaling
OS-093 Efficient and heritable elimination of HBV viral antigens in vivo by epigenome editing
Polyploidisation pleiotropically buffers ageing in hepatocytes
Retraction notice to “Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance” [J Hepatol 74 (5) 2021 1038–1052]
SAT-338-YI Using retrieval augmented generation to increase large language models accuracy: a proof-of-concept pipeline on european hepatitis C virus (HCV) guidelines
SAT-373 Intrahepatic sodium taurocholate co-transporting polypeptide gene transcript and membrane-localized protein expression changes in chronic hepatitis D patients following 48 weeks of treatment w
SAT-423 Highly expressed CTLA4 on B cells defected BCR signal to inhibit the secretion of anti-HBs in CHB patients
SAT-469 Artificial intelligence for classifying liver lesions in contrastenhanced ultrasound
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver
THU-201-YI Artificial intelligence-assisted multiomics depicting the immunometabolism landscape of steatotic livers undergoing bariatric surgery
THU-261 Artificial intelligence models deployed at scale on hematoxylin and eosin-stained whole slide images reveal stage-dependent collagen composition in metabolic dysfunction-associated steatohepat
THU-280 DC-SIGN+ macrophages alleviates non-alcoholic steatohepatitis by modulating inflammatory cytokine secretion
THU-284 Prediction of MASH features from liver biopsy images using a pretrained self-supervised learning model
TOP-006 Development and validation of a home-based score to detect advanced liver fibrosis and long-term liver-related outcomes in the general population: a multicohort study
TOP-520 Machine learning for risk stratification of hepatocellular carcinoma
WED-078 Systemic albumin administration improves the gut microbiome and intestinal permeability in animal models of cirrhosis and ACLF
WED-242 The use of ELF test, FIB-4 and sequential algorithms to screen the Type 2 Diabetes Mellitus (T2DM) population for advanced fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease